Jo-Ann Johnson MD, Presenter: Nothing to Disclose

1) To review the role of the 11-14 week scan in screening for chromosomal abnormalities and birth defects. 2) To provide an update on all aspects of nuchal translucency screening. 3) To review the current status of the "newer" first TM markers (nasal bone, ductus venosus, tricuspid regurgitation, facial angle). 4) To demonstrate that combining the 11-14 week scan with maternal biochemistry in the first TM not only predicts aneuploidy but also adverse pregnancy outcome.

http://www.mfmedicine.com/SyllabusForRSNA.aspx

Johnson, J, The 11 - 14-Week Scan: An Update.  Radiological Society of North America 2007 Scientific Assembly and Annual Meeting, November 25 - November 30, 2007 ,Chicago IL. http://archive.rsna.org/2007/5000190.html